Drug discontinuation: Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops (CIPRO HC)
FDA lists 1 presentation as To Be Discontinued. Companies: Sandoz Inc..
- Published by source
- 2026-10-30
- First seen by Reality Radar
- 2026-10-30
- Last verified
- 2026-10-30
Affected
- Manufacturer
- Sandoz Inc.
- Products
- Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops CIPRO HC
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Discontinuation of the manufacturing of NDC 66758-087-70. Authorized generic is available under new NDC 0781-6218-70
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-10-30
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #3321 | new | 2026-10-30 | 5694a6572c7f…58b3d8 | e2c5df07234f…e65be8 |
Chain head: #3332 f9027bc95d35…745b9e